Search results
Results from the WOW.Com Content Network
Novartis paid $1.2 million to Essential Consultants, an entity owned by Michael Cohen, following the 2017 inauguration of Donald Trump. Cohen was paid monthly, with each payment just under $100,000. Novartis claims it paid Cohen to help it understand and influence the new administration's approach to drug pricing and regulation. [209]
Chiron Corporation (/ ˈ k aɪ r ɒ n / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006.
Inspira Health has 1,328 medical staff members, 907 volunteers, and 5,782 employees. [1] It is affiliated with the Jefferson Medical College, Rowan-Virtua School of Osteopathic Medicine, and Philadelphia College of Pharmacy, among others. [2] In 2021 it was given a grade A by the Leapfrog patient safety organization. [3]
For premium support please call: 800-290-4726 more ways to reach us
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.
MorphoSys’ main technology is HuCAL (Human Combinatorial Antibody Library), which is a collection of more than ten billion fully human antibodies in the form of a phage display bank and a system for their optimization. [27] Another technology recently developed is the OkapY bispecific antibody technology.
The total amount comprises $2 billion in civil charges under the False Claims Act and $1 billion in criminal charges related to its misbranding and lacking safety reports for its products Paxil ...